The Asia-Pacific CRISPR market is anticipated to record a CAGR of 21.18% over the estimated years of 2021 to 2028. The regional market’s growth is credited to key factors such as the rising dependency of consumers on non-vegetarian foods such as poultry meat, red meat, and seafood, the presence of well-recognized agriculture research facilities for developing productive and effective crops, and increased research and development (R&D) activities implemented in emerging economies.

ASIA-PACIFIC CRISPR MARKET FORECAST 2021-2028

Asia Pacific CRISPR Market by Product (Plasmids, Vectors, Proteins, Designing Tools, Grna, Control Kits, Library, Other Products) Market by Application (Genome Editing/genetic Engineering, CRISPR Plasmid, Human Stem Cells, Grna Database/gene Library, Cell Line Engineering) Market by End-user (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech) by Geography

Request free sample

Report Summary

To learn more about this report, request a free sample copy

The Asia-Pacific CRISPR market growth study entails the assessment of India, Singapore, Malaysia, South Korea, Thailand, Australia & New Zealand, China, Japan, and the rest of the Asia-Pacific. Japan continues to witness substantial growth in terms of innovation within CRISPR technology. For instance, in 2021, Sanatech Seed launched the foremost direct consumption genome-edited tomato in the country. However, in this regard, the Japanese ministries in charge announced that the genome-edited tomato would not be regulated as a genetically modified product.

On the other hand, new research on CRISPR is set to propel market growth in India. In 2019, for example, the country’s scientists developed a novel variant of the presently popular gene-editing tool, CRISPR-Cas9. The variant has the potential to increase precision in editing the genome while evading unintended DNA changes. Thus, these factors are set to influence the CRISPR market in the Asia-Pacific during the forecasted years.

Intellia Therapeutics, headquartered in the United States, is a genome editing company involved in developing exclusive, potentially curative therapeutics utilizing the recent biological tool termed CRISPR/Cas9 system. The combination of extensive clinical development experience and profound scientific expertise places the company in a unique position to unravel broad therapeutic applications of the CRISPR/Cas9 technology.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
MARKET DYNAMICS
- KEY DRIVERS
  - RISK OF CONGENITAL ANOMALIES
  - PREVALENCE OF GENETIC DISORDERS
  - GROWING USE OF CRISPR IN AGRICULTURE
  - RISING AWARENESS REGARDING GENE THERAPEUTICS
- KEY RESTRAINTS
  - POSSIBLE MISUSE OF CRISPR GENE-EDITING TOOL
  - LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
  - ETHICAL ISSUES

KEY ANALYTICS
- IMPACT OF COVID-19 ON CRISPR MARKET
- PATENT ANALYSIS
- FUNDING SCENARIO
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
  - BUYERS POWER
  - SUPPLIERS POWER
  - SUBSTITUTION
  - NEW ENTRANTS
  - INDUSTRY RIVALRY
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- KEY BUYING CRITERIA
  - COST
  - ACCURACY
  - EASY TO USE
- LEGAL & REGULATORY FRAMEWORK
MARKET BY PRODUCT
- PLASMIDS
- VECTORS
- PROTEINS
- DESIGNING TOOLS
- GRNA
- CONTROL KITS
- LIBRARY
- OTHER PRODUCTS
MARKET BY APPLICATION
- GENOME EDITING/GENETIC ENGINEERING
- CRISPR PLASMID
- HUMAN STEM CELLS
- GRNA DATABASE/GENE LIBRARY
- CELL LINE ENGINEERING
MARKET BY END-USER
- THERAPEUTICS AND DRUG DISCOVERY
- BIOLOGICAL RESEARCH
- AGRICULTURAL BIOTECH
- INDUSTRIAL BIOTECH
GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - INDIA
    - SOUTH KOREA
    - SINGAPORE
    - THAILAND
    - MALAYSIA
    - AUSTRALIA & NEW ZEALAND
    - REST OF ASIA-PACIFIC

COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
  - MERGERS & ACQUISITIONS
  - PRODUCT LAUNCHES & DEVELOPMENTS
  - PARTNERSHIPS & AGREEMENTS
  - BUSINESS EXPANSIONS & DIVESTITURES
- COMPANY PROFILES
  - ADDGENE
  - CARIBOU BIOSCIENCES INC
  - CELLECTIS BIORESEARCH SAS
  - CRISPR THERAPEUTICS AG
  - EDITAS MEDICINE
  - GENSCRIPT
  - HORIZON DISCOVERY GROUP
  - INTEGRATED DNA TECHNOLOGIES
  - INTELLIA THERAPEUTICS
  - LONZA GROUP LTD
  - NEW ENGLAND BIOLABS
  - NOVARTIS INTERNATIONAL AG
  - ORIGENE TECHNOLOGIES INC
  - PRECISION BIOSCIENCES
  - SYNTHEGO CORPORATION
  - THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – CRISPR

TABLE 2: FUNDING SCENARIO OF PUBLIC COMPANIES

TABLE 3: FUNDING SCENARIO OF PRIVATE COMPANIES

TABLE 4: FUNDING SCENARIO OF GOVERNMENT ORGANIZATIONS

TABLE 5: REGULATORY FRAMEWORK

TABLE 6: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: ASIA-PACIFIC CRISPR MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: ASIA-PACIFIC CRISPR MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CRISPR MARKET

TABLE 15: LIST OF MERGERS & ACQUISITIONS

TABLE 16: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 17: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 18: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION

FIGURE 2: KEY MARKET TRENDS

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

FIGURE 8: ASIA-PACIFIC CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)

FIGURE 11: ASIA-PACIFIC CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

FIGURE 14: ASIA-PACIFIC CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 17: ASIA-PACIFIC CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

FIGURE 18: ASIA-PACIFIC CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)

FIGURE 22: ASIA-PACIFIC CRISPR MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 23: ASIA-PACIFIC CRISPR MARKET, BY THERAPEUTICS AND DRUGS DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 25: ASIA-PACIFIC CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)

FIGURE 26: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)

FIGURE 27: ASIA-PACIFIC CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 28: CHINA CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: JAPAN CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: INDIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: SOUTH KOREA CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: SINGAPORE CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: THAILAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: MALAYSIA CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: AUSTRALIA & NEW ZEALAND CRISPR MARKET, 2021-2028 (IN $ MILLION)

FIGURE 36: REST OF ASIA-PACIFIC CRISPR MARKET, 2021-2028 (IN $ MILLION)

Segmentation

GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
  - MARKET SIZE & ESTIMATES
  - KEY GROWTH ENABLERS
  - KEY CHALLENGES
  - KEY PLAYERS
  - COUNTRY ANALYSIS
    - CHINA
    - JAPAN
    - INDIA
    - SOUTH KOREA
    - SINGAPORE
    - THAILAND
    - MALAYSIA
    - AUSTRALIA & NEW ZEALAND
    - REST OF ASIA-PACIFIC

MARKET BY PRODUCT
- PLASMIDS
- VECTORS
- PROTEINS
- DESIGNING TOOLS
- GRNA
- CONTROL KITS
- LIBRARY
- OTHER PRODUCTS
MARKET BY APPLICATION
- GENOME EDITING/GENETIC ENGINEERING
- CRISPR PLASMID
- HUMAN STEM CELLS
- GRNA DATABASE/GENE LIBRARY
- CELL LINE ENGINEERING
MARKET BY END-USER
- THERAPEUTICS AND DRUG DISCOVERY
- BIOLOGICAL RESEARCH
- AGRICULTURAL BIOTECH
- INDUSTRIAL BIOTECH

Request Free Sample

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.